Provided by Tiger Trade Technology Pte. Ltd.

Arrowhead Pharmaceuticals

69.12
+3.545.40%
Post-market: 68.55-0.5700-0.82%17:01 EST
Volume:1.85M
Turnover:127.14M
Market Cap:9.68B
PE:-5.67K
High:69.85
Open:65.58
Low:65.45
Close:65.58
52wk High:76.76
52wk Low:9.57
Shares:140.01M
Float Shares:120.00M
Volume Ratio:0.97
T/O Rate:1.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0122
EPS(LYR):-0.0122
ROE:8.67%
ROA:4.87%
PB:20.76
PE(LYR):-5,668.83

Loading ...

Earning Preview: Arrowhead Pharmaceuticals — revenue is expected to increase, and institutional views tilt positive

Earnings Agent
·
Yesterday

BUZZ-Arrowhead rises as it begins trial of high-cholesterol disorder drug

Reuters
·
Jan 27

Arrowhead Pharmaceuticals Doses First Subject in Clinical Trial of Treatment for Mixed Hyperlipidemia

MT Newswires Live
·
Jan 27

Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of Aro-Dimer-Pa – the First Dual Functional Rnai Therapeutic for the Treatment of Mixed Hyperlipidemia

THOMSON REUTERS
·
Jan 27

Arrowhead Pharmaceuticals Inc. Announces Date for Upcoming Annual Stockholders Meeting

Reuters
·
Jan 27

Arrowhead Pharmaceuticals (ARWR) Is Up 5.0% After China Approves Redemplo Commercialisation With Sanofi

Simply Wall St.
·
Jan 25

B. Riley Raises Price Target on Arrowhead Pharmaceuticals to $101 From $61, Keeps Buy Rating

MT Newswires Live
·
Jan 22

Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE), Arrowhead Pharmaceuticals (ARWR) and Alector (ALEC)

TIPRANKS
·
Jan 21

Arrowhead Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jan 21

Arrowhead Pharmaceuticals : H.c. Wainwright Raises Target Price to $100 From $85

THOMSON REUTERS
·
Jan 21

Arrowhead price target raised to $100 from $85 at H.C. Wainwright

TIPRANKS
·
Jan 21

U.S. RESEARCH ROUNDUP-IBM, KLA, WEX

Reuters
·
Jan 21

Arrowhead Pharmaceuticals Inc. to Webcast Fiscal 2026 First Quarter Results

Reuters
·
Jan 21

Arrowhead Pharmaceuticals Price Target Raised to $110.00/Share From $100.00 by Piper Sandler

Dow Jones
·
Jan 13

U.S. RESEARCH ROUNDUP-Cencora, Kennametal, Regeneron Pharmaceuticals

Reuters
·
Jan 13

Arrowhead Pharmaceuticals Issues Zero-Coupon 2032 Convertible Notes

TIPRANKS
·
Jan 13

Arrowhead Pharmaceuticals - Issues $700 Mln of 0.00% Convertible Notes Due 2032 - SEC Filing

THOMSON REUTERS
·
Jan 13

Arrowhead Pharmaceuticals Issues $700 Million Convertible Senior Notes Due 2032

Reuters
·
Jan 13

Innovative Drug Sector's Booster Shot! Piper Sandler Bets on "Gene Silencing" Leader Arrowhead (ARWR.US), Predicts Stock to Soar 55%

Stock News
·
Jan 12

How Investors May Respond To Arrowhead Pharmaceuticals (ARWR) China Approval Expanding REDEMPLO RNAi Metabolic Footprint

Simply Wall St.
·
Jan 11